https://metherapeutics.uxbomb.com/lorem-ipsum-dolor-sit-amet-consectetur/2023-12-07T13:46:58+00:00https://metherapeutics.uxbomb.com/lorem-ipsum-dolor-sit-amet-consectetur-4/2023-12-07T13:33:07+00:00https://metherapeutics.uxbomb.com/lorem-ipsum-dolor-sit-amet-consectetur-3/2023-12-07T13:40:22+00:00https://metherapeutics.uxbomb.com/lorem-ipsum-dolor-sit-amet-consectetur-2/2023-12-09T13:47:14+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-provides-an-overview-and-update-on-current-research-and-development-programs/2023-12-07T08:44:46+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-annouces-listing-on-the-frankfurt-stock-exchange-fse-and-the-completion-of-its-redesigned-website/2023-12-15T18:18:03+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-provides-corporate-updates/2024-02-14T19:35:23+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-non-brokered-private-placement/2024-03-01T20:05:15+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-closing-of-non-brokered-private-placement/2024-04-04T21:22:09+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-upcoming-participation-in-the-2024-bloom-burton-co-health-care-conference-and-interview-on-cse-tv/2024-04-04T21:27:23+00:00https://metherapeutics.uxbomb.com/me-therapeutics-to-present-at-investor-clubhouse-at-the-canadian-open-and-attend-the-2024-bio-international-convention-for-partnering-opportunities/2024-05-17T17:26:05+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-announces-the-addition-of-two-new-clinical-consultants-to-continue-the-advancement-of-our-lead-anti-g-csf-antibody-candidate-towards-a-first-in-human-clinical-trial/2024-07-18T18:28:51+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-new-collaboration-with-nanovation-therapeutics-on-advanced-therapeutic-mrna-delivery-to-myeloid-cells/2024-07-18T18:28:05+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-the-start-of-testing-of-first-mrna-formulations-from-nanovation-therapeutics-collaboration/2024-10-23T16:45:57+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-provides-research-and-development-update-and-corporate-update/2024-10-23T16:49:02+00:00https://metherapeutics.uxbomb.com/me-therapeutics-holdings-inc-appoints-chief-business-officer/2024-10-28T18:10:31+00:00https://metherapeutics.uxbomb.com/me-therapeutics-announces-it-has-engaged-lucosky-brookman-llp-to-explore-a-listing-on-the-nasdaq-or-nyse/2025-04-10T09:30:17+00:00